Dudeja P K, Wali R K, Klitzke A, Sitrin M D, Brasitus T A
Department of Medicine, University of Chicago, Illinois 60637.
J Clin Invest. 1991 May;87(5):1755-62. doi: 10.1172/JCI115194.
Diabetes was induced in rats by administration of a single i.p. injection of streptozotocin (50 mg/kg body wt). After 7 d, diabetic rats were further treated with insulin or 1,25-dihydroxycholecalciferol [1,25(OH)2D3] for an additional 5-7 d. Control, diabetic, diabetic + insulin, and diabetic + 1,25(OH)2D3 rats were then killed, their proximal small intestines were removed, and villus-tip epithelial cells were isolated and used to prepare brush-border membrane vesicles. Preparations from each of these groups were then analyzed and compared with respect to their amiloride-sensitive, electroneutral Na(+)-H+ exchange activity, using 22Na uptake as well as acridine orange techniques. The results of these experiments demonstrated that (a) H+ gradient-dependent 22Na uptake as well as Na+ gradient-dependent transmembrane H+ fluxes were significantly increased in diabetic vesicles compared to their control counterparts, (b) kinetic studies demonstrated that this enhanced 22Na uptake in diabetes was a result of increased maximal velocity (Vmax) of this exchanger with no change in apparent affinity (Km) for Na+, (c) serum levels of 1,25(OH)2D3 were significantly lower in diabetic animals compared with their control counterparts; and (d) insulin or 1,25(OH)2D3 treatment restored the Vmax alterations to control values, without any significant changes in Km, concomitant with significantly increasing the serum levels of 1,25(OH)2D3 in diabetic animals. These results indicate that Na(+)-H+ activity is significantly increased in proximal small intestinal luminal membranes of streptozotocin-induced diabetic rats. Moreover, alterations in the serum levels of 1,25(OH)2D3 may, at least in part, explain this enhanced antiporter activity and its correction by insulin.
通过腹腔注射一次链脲佐菌素(50毫克/千克体重)诱导大鼠患糖尿病。7天后,对糖尿病大鼠进一步用胰岛素或1,25 - 二羟基胆钙化醇[1,25(OH)₂D₃]治疗5 - 7天。然后处死对照、糖尿病、糖尿病 + 胰岛素和糖尿病 + 1,25(OH)₂D₃组的大鼠,取出它们的近端小肠,分离绒毛顶端上皮细胞并用于制备刷状缘膜囊泡。然后对这些组中的每组制备物进行分析,并使用²²Na摄取以及吖啶橙技术,就其对氨氯地平敏感的电中性Na⁺ - H⁺交换活性进行比较。这些实验结果表明:(a)与对照囊泡相比,糖尿病囊泡中H⁺梯度依赖性²²Na摄取以及Na⁺梯度依赖性跨膜H⁺通量显著增加;(b)动力学研究表明,糖尿病中这种增强的²²Na摄取是该交换体最大速度(Vmax)增加的结果,而对Na⁺的表观亲和力(Km)没有变化;(c)与对照动物相比,糖尿病动物血清中1,25(OH)₂D₃水平显著降低;(d)胰岛素或1,25(OH)₂D₃治疗将Vmax改变恢复到对照值,Km无任何显著变化,同时显著提高糖尿病动物血清中1,25(OH)₂D₃水平。这些结果表明,链脲佐菌素诱导的糖尿病大鼠近端小肠腔膜中的Na⁺ - H⁺活性显著增加。此外,1,25(OH)₂D₃血清水平的改变可能至少部分解释了这种增强的反向转运体活性及其被胰岛素纠正的现象。